The force of HER2 – A druggable target in NSCLC?
M. Jebbink, Adrianus J. de Langen, Mirjam C. Boelens, Kim Monkhorst, Egbert F. Smit
Topics & Concepts
DruggabilityMedicineTargeted therapyFluorescence in situ hybridizationOncologyInternal medicineImmunohistochemistryBioinformaticsCancer researchGeneCancerBiologyGeneticsChromosomeHER2/EGFR in Cancer ResearchLung Cancer Treatments and MutationsLymphoma Diagnosis and Treatment